Share to Facebook Share to Twitter Bookmark and Share
File #: 200013    Version: 1 Name: Agreement - Retroactive - McKesson Plasma and Biologics LLC - Pharmaceuticals, Biologics and Specialty Drugs - Not to Exceed $295,934,790
Type: Resolution Status: Passed
Introduced: 1/7/2020 In control: Clerk of the Board
On agenda: 1/7/2020 Final action: 4/3/2020
Enactment date: 4/3/2020 Enactment #: 124-20
Title: Resolution retroactively approving an agreement between McKesson Plasma and Biologics LLC and the Department of Public Health for the purchase of pharmaceutical products, biologics and specialty drugs for a total amount not to exceed $295,934,790 for a term of five years, from February 1, 2020, through January 31, 2024.
Attachments: 1. Leg Ver1, 2. DRAFT Agrmt, 3. Form 126, 4. BLA Report 021220, 5. Comm Pkt 021220, 6. Board Pkt 032420, 7. DPH Ltr 032020, 8. Leg Final, 9. Form 126 Final
Legislation Details
 *NOTE: These reports are produced in HTML format and are accessible to screen readers.